Skip to main content

1 Result(s)

within N Chapuis Remove this filter Biomedicine, general Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma

    Vemurafenib is a BRAF kinase inhibitor approved for first-line treatment of metastatic BRAF V600 -mutant melanoma. However, data on the pharmacokinetic/...

    N. Kramkimel, A. Thomas-Schoemann, L. Sakji, JL. Golmard, G. Noe… in Targeted Oncology (2016)